Iron chelation therapy improves hematopoiesis in patients with hematological malignancy after hematopoietic stem cell transplantation

Código QR

Iron chelation therapy improves hematopoiesis in patients with hematological malignancy after hematopoietic stem cell transplantation

Objective To investigate the effect and safety of iron chelation therapy on hematopoiesis in hematological malignancy patients with iron overload after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Methods The clinical data of 38 hematological malignancy patients who suffered from...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	ZENG Cong, CHEN Xu, HUA Juan, CHENG Tingting, MA Xia, XU Yajing
Formato:	article
Lenguaje:	ZH
Publicado:	Editorial Office of Journal of Third Military Medical University 2021
Materias:	allogeneic hematopoietic stem cell transplantation iron chelation therapy hematopoiesis Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/aff6134d7f3e4637b48cc93cef7c13a5
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Hematopoietic stem cell transplantation: clinical use and perspectives
por: Barriga,Francisco, et al.
Publicado: (2012)

Recent insights into hematopoiesis in crustaceans
por: Man-jun Liu, et al.
Publicado: (2021)

Improvement of hematopoietic stem cell transplantation in the targeted therapy era
por: ZHANG Xi, et al.
Publicado: (2021)

Risk factors for late-onset hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: analysis of 227 cases
por: XIONG Yiying, et al.
Publicado: (2021)

CD4+ T cells in aged or thymectomized recipients of allogeneic stem cell transplantations
por: Takahashi,Hiroshi, et al.
Publicado: (2015)

Efficacy and safety of posaconazole in prevention of invasive fungal infections during allogeneic hematopoietic stem cell transplantation: a single-center retrospective analysis
por: ZHANG Yanfang, et al.
Publicado: (2021)

IMMUNE STATE IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES AT LATE TERMS AFTER AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: N. V. Minaeva, et al.
Publicado: (2014)

Letermovir Prophylaxis and Cytomegalovirus Reactivation in Adult Hematopoietic Cell Transplant Recipients with and without Acute Graft Versus Host Disease
por: Delaney Wolfe, et al.
Publicado: (2021)

Charlson comorbidity index predicts outcomes of elderly after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndrome
por: Sheng-Hsuan Chien, et al.
Publicado: (2021)

Biofortification of cowpea beans with iron: iron´s influence on mineral content and yield
por: Márquez-Quiroz,C, et al.
Publicado: (2015)

Cytokine Release Syndrome in the Immunotherapy of Hematological Malignancies: The Biology behind and Possible Clinical Consequences
por: Tor Henrik Anderson Tvedt, et al.
Publicado: (2021)

Prognostic Factors and Clinical Considerations for Iron Chelation Therapy in Myelodysplastic Syndrome Patients
por: Parisi S, et al.
Publicado: (2021)

Long-Term Effects of Iron Chelating Agents on Ocular Function in Patients with Thalassemia Major
por: Nuzzi R, et al.
Publicado: (2021)

Chelators for Treatment of Iron and Copper Overload: Shift from Low-Molecular-Weight Compounds to Polymers
por: Martin Hruby, et al.
Publicado: (2021)

CLINICAL EFFECTS OF MESENCHYMAL STROMAL CELLS IN LYMPHOMA PATIENTS WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: E. V. Batorov, et al.
Publicado: (2012)

Subcutaneous immunoglobulin in allogeneic hematopoietic cell transplant patients: A prospective study of feasibility, safety, and healthcare resource use
por: Ivan Pasic, et al.
Publicado: (2021)

Polyphosphate Functions <italic toggle="yes">In Vivo</italic> as an Iron Chelator and Fenton Reaction Inhibitor
por: François Beaufay, et al.
Publicado: (2020)

Sirolimus versus imatinib in patients with steroid-refractory chronic graft-versus-host disease: a retrospective analysis of a single-center
por: HE Yundi, et al.
Publicado: (2021)

Anatomy of Hematopoiesis and Local Microenvironments in the Bone Marrow. Where to?
por: Qingqing Wu, et al.
Publicado: (2021)

Mutation analysis links angioimmunoblastic T-cell lymphoma to clonal hematopoiesis and smoking
por: Shuhua Cheng, et al.
Publicado: (2021)

Ruxolitinib for Treatment of Steroid-Refractory Graft-versus-Host Disease: Real-World Data from Chinese Patients
por: Wei C, et al.
Publicado: (2021)

Effect of Amnion-Wrapped Allogenic Nerve Bridging on Peripheral Nerve Injury
por: Zhang,Yan-Ru, et al.
Publicado: (2013)

Extramedullary Hematopoiesis in a Man With β-Thalassemia: An Uncommon Cause of an Adrenal Mass
por: Shahryar Zeighami, et al.
Publicado: (2015)

Positive asymptotically almost periodic solutions of an impulsive hematopoiesis model
por: Chen,Peng, et al.
Publicado: (2016)

Differentiation of Yin, Yang and Stasis Syndromes in Severe Aplastic Anemia Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation and Their Correlation with Iron Metabolism, cAMP/cGMP, 17-OH-CS and Thyroxine
por: Hu H, et al.
Publicado: (2021)

Intoxicación aguda por hierro en un caso
por: Jover D,Francisco, et al.
Publicado: (2001)

Editorial: The Role of Hematopoietic Progenitors in Immune Regulation and Memory
por: Flora Zavala, et al.
Publicado: (2021)

Biology of blood and marrow transplantation journal of the American Society for Blood and Marrow Transplantation.
Publicado: (1995)

Hepatitis B Virus Infection in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation
por: Yi-Chang Liu, et al.
Publicado: (2021)

Iron in Cardiovascular Disease: Challenges and Potentials
por: Shizhen Li, et al.
Publicado: (2021)

Improving Longitudinal Transversal Relaxation Of Gadolinium Chelate Using Silica Coating Magnetite Nanoparticles
por: Xu K, et al.
Publicado: (2019)

Hematopoietic potential of mouse placenta with the application of placenta flushing
por: WEI,BIN, et al.
Publicado: (2008)

ACTIVATION OF T. GONDII INFECTION AFTER ALLOGENEIC TRANSPLANTATION OF HEMATOPOIETIC STEM CELLS: DEPENDENCE ON TIME OF TRANSPLANTATION AND SEROLOGICAL STATUS OF THE PATIENTS
por: A. B. Chukhlovin, et al.
Publicado: (2015)

Histocompatibility and Immunogenetics in Cord Blood Transplantation
por: Rubinstein,Pablo, et al.
Publicado: (2010)

Mathematical Modeling of Within-Host, Untreated, Cytomegalovirus Infection Dynamics after Allogeneic Transplantation
por: Elizabeth R. Duke, et al.
Publicado: (2021)

Autologous Hematopoietic Stem Cell Transplantation (AHSCT): An Evolving Treatment Avenue in Multiple Sclerosis
por: Mohammadi R, et al.
Publicado: (2021)

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN FANCONI ANEMIA; A SINGLE CENTRE EXPERIENCE
por: Tariq Azam Khattak, et al.
Publicado: (2021)

Phenotypes, Lung Microbiota and Cytokine Responses in Pneumonia After Hematopoietic Stem Cell Transplantation
por: Hu Y, et al.
Publicado: (2021)

Survival following relapse after allogeneic hematopoietic cell transplantation for acute leukemia and myelodysplastic syndromes in the contemporary era
por: Sanghee Hong, et al.
Publicado: (2021)

Hepatic sinusoidal obstruction syndrome/veno-occlusive disease after hematopoietic cell transplantation: historical and current considerations in Korea
por: Jae-Ho Yoon, et al.
Publicado: (2021)